u/teodor_jansen

Small fix — same supplier, different lot. The two rows in the log are not the same batch.

quantity limits are as common a barrier as coverage itself

That service reports area percent by default. Worth stating, since the thread has been comparing it to a mass figure.

Same.

Agreed — and two services on one batch is the strongest thing any of us can produce individually.

Research-use-only material is not approved for human use. That is a plain statement of regulatory fact and it belongs in every beginner thread.

Yes. Approval and coverage are separate, and this board conflates them in about half its threads.

titration means going slow on the way up

a rejected claim is not the same as a denied authorization

Bacteriostatic water contains a preservative, which is what makes repeated entry into a vial reasonable. Sterile water does not, and the two are not interchangeable for that purpose.

Escrow is not standard in this space. Wanting it is reasonable; expecting it as default is not.

Same. Asking which networks are accepted before ordering has saved me twice.

Right, and net peptide content is where the counterion and the water go. Both numbers can be honest and very different.

Agreed. Network first, address second, amount third, and in that order every time.

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

Did you write the concentration on the vial?

What week are you in?

the same product can be covered in one province and not the next

A test transaction costs one extra network fee and verifies the address, the network and the recipient’s crediting process before the main amount moves.

Nothing on this board is medical advice, and the people answering you — including me — are members with spreadsheets rather than clinicians.

Slight disagreement with this bit only, because a beginner reading it might take it as a plan rather than a description.

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.

Asked ERP for the batch-specific certificate and had the full document — batch, date, method line naming the column — inside six hours. That is now my baseline for everybody.

I would not treat a delayed confirmation as evidence of anything at all. Chains have busy hours.

vendor, compound, batch, service, result — that is the template

The document I was worried about turned out to be a re-issue with a later creation date. Asked, got the original, entirely ordinary.

Yes. The structure of the document matters at least as much as the number printed on it.

Provincial plan, employer plan, or paying cash?

net peptide content if the report gives it, and say which you are quoting

send a test amount first if the total is large

net peptide content and purity are two different numbers on the same vial

redact your own name, never the batch details

Disagree that a lower number is automatically worse. A conservative claim that survives testing is worth more than an optimistic one that does not.

Which networks did they list as accepted?

Right, and confirmations are the status. "Sent" means nothing until the chain agrees.

Did you ask for the batch-specific document, or is this the catalogue one?

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

Chain of custody is why member-funded testing is worth more than a supplied certificate: the vial tested is the vial that arrived at a member’s door.

the lot on the vial has to match the lot on the page